SZSE: 002223 - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Yield per half year: -11.71%
Sector: Healthcare

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
18.61 69.4 -73.18% 20.38 -8.68%
P/S 4.3 6.51 -33.92%
P/BV 3.29 3.96 -16.84%
P/FCF 0 0 0%
Ev/Ebitda 13.67 11.85 15.37%
Ev/S 3.75 5.98 -37.32%
Ev/FCF 0 0 0%
E/P 0.0529 0.0396 33.61%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
21.52 16.34 31.7% 26.79 -19.68%
ROE 18.53 11.95 55.12%
ROA 7.65 5.4 41.62%
ROIC 0 0 0%
ROS 23.06 16.23 42.06%
ROCE 0 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.9063 14.63 -93.8% 0.9063 0%
Nеt Debt/Ebitda 0 0 0%
Debt/Ratio 0 0 0%
Debt/Equity 0 0 0%
Debt/Net Income 0.9457 3.6 -73.73%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
4.33/10
1.73 1.83 -5.62% 1.14 +51.64%
Number of years of dividend growth 1 1.44 -30.43%
DSI 0.9286 0.9113 1.89%
Average dividend growth 9.49 10.4 -8.7%
Average percentage for 5 years 1.14 1.14 -0.103%
Average percentage for payments 30.08 44.8 -32.86%
Difference from average difference in sector -0.103

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
71.96 61.43 17.14%
Growth impulse Ebitda in 5 years 125.77 158.62 -20.71%
Growth impulse Net Income in 5 years 218.36 66.93 226.25%
Growth impulse FCF in 5 years 1047.44 248.41 321.66%
Growth impulse EPS in 5 years 174.55 73.29 138.16%
IP Score
7.09/10

Similar companies

Aier Eye Hospital Group Co., Ltd.

Imeik Technology Development Co.,Ltd.

Hangzhou Tigermed Consulting Co., Ltd

Chongqing Zhifei Biological Products Co

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription